Human uPA PharmaGenie ELISA Kit (SBRS1218)

Urokinase-type plasminogen activator (uPA, also known as PLAU) is a serine protease that converts plasminogen to plasmin, linking fibrinolysis to extracellular matrix turnover, cell migration, and tumor invasion. Quantifying uPA levels in research samples supports studies in oncology, angiogenesis, wound healing, and tissue remodeling.

This Assay Genie kit provides a quantitative immunoassay for human urokinase plasminogen activator, configured to measure the protein in cell culture supernatant, plasma, and serum specimens. The plate-based colorimetric workflow delivers 96 assays per kit, supporting moderate-throughput screening of clinical and experimental samples. The assay is intended for research use only and has been validated for reactivity with human samples.

Components arrive refrigerated for short-term use; long-term storage at -20 °C preserves reagent stability across multiple freeze-thaw cycles, and aliquoting is recommended to limit repeated exposure of the antibody-coated plate. Researchers investigating breast cancer prognosis, inflammatory disease pathways, or urokinase pharmacology will find the kit applicable to biomarker quantification in vitro workflows, including exploratory studies of metastatic potential and fibrinolytic balance.